CATEGORY
CytoDyn Inc (OTCMKTS: CYDY) Steady Rise Northbound as New President Takes Control & Implements Ambitious Plans for Leronlimab (PRO 140)
Q BioMed Inc (OTCMKTS: QBIO) Big Move as Biotech Reports US Patent for Uttroside B Expected as Pre-Clinical Testing Supports Advancing Program for Liver...
Enzolytics Inc (OTCMKTS: ENZC) On the Move as Co Files Audited Financials & Reports ITV-1 Anti-HIV Therapeutic is Safe & Non-Toxic (More on EMA...
American International Holdings Corp (OTCMKTS: AMIH) Heating Up After Big Reversal off 52 Week Lows (Spotlight on COSM ZipDoctor Acquisition)
PSYC Corporation (OTCMKTS: PSYC) Breakout Northbound on Psychedelicspotlight.com Continued Growth as Co Looks to go QB
Anavex Life Sciences Corp (NASDAQ: AVXL) Steady Rise Up the Charts on Positive ANAVEX®2–73 (Blarcamesine) Phase 2B/3 Data as February 7 Conference Call Looms
Spotlight on Northwest Biotherapeutics, Inc., (OTCQB: NWBO) As Co Releases Important Update on Shareholders Meeting & 2023 Plans (More on Positive Top-Line Results from...
Skye Bioscience Inc (OTCMKTS: SKYE) Heats Up as its SBI-100 OE Phase 1 Clinical Trial to Treat Glaucoma Progresses
A Close Look at Electromedical Technologies Inc (OTCMKTS: EMED)
Panacea Life Sciences Holdings Inc (OTCMKTS: PLSH) Reversing Northbound as Company Announces LOI to Acquire 100% of N7 Enterprises